| Issue Type | Login |
|---|---|
| Country | United States |
| Industry | Login |
| Region | Login |
| Maturity Date | 2031-01-15 |
| Par Value | 2000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 400.00 |
| Coupon | 5.05 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 400.000 |
| Min. Piece | Login |
| Min. Increment | Login |
This Biogen Inc corporate note has a 5.05% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 400.00 million USD and matures on January 15, 2031 with a last coupon date of FEB 28, 2020. |
Biogen Inc, founded in 1978 and headquartered in Cambridge, Massachusetts, is a global biotechnology company dedicated to developing innovative therapies for neurodegenerative diseases. The company's main focus includes treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and Alzheimer’s disease, positioning it as a leader in the biopharmaceutical industry.